ABSTRACT The steady increase in the number of health technologies and advances in associated research generate management challenges in the choice of technologies to be made available to the public. F
This dataset contains the R analysis script (v2.0) and all six publication-quality figures generated for the cost-consequence analysis comparing daptomycin-based outpatient parenteral antimicrobial th
Objective The effectiveness of sugemalimab vs. placebo in post-chemoradiotherapy patients with locally advanced, unresectable stage III NSCLC has been demonstrated and approved by China National Medic
